Proto Script Pharmaceutical Corp
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Proto Script Pharmaceutical Corp (PSCR) - Net Assets
Latest net assets as of September 2017: $-1.44 Million USD
Based on the latest financial reports, Proto Script Pharmaceutical Corp (PSCR) has net assets worth $-1.44 Million USD as of September 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($234.56K) and total liabilities ($1.68 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.44 Million |
| % of Total Assets | -614.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | -198.83% |
| 10-Year Change | N/A |
| Growth Volatility | 160.69 |
Proto Script Pharmaceutical Corp - Net Assets Trend (2010–2016)
This chart illustrates how Proto Script Pharmaceutical Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Proto Script Pharmaceutical Corp (2010–2016)
The table below shows the annual net assets of Proto Script Pharmaceutical Corp from 2010 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-12-31 | $-319.74K | -314.91% |
| 2016-06-30 | $-77.06K | 0.00% |
| 2016-05-31 | $-77.06K | -223.81% |
| 2015-12-31 | $62.24K | -80.76% |
| 2014-12-31 | $323.52K | +1254.35% |
| 2013-12-31 | $-28.03K | -200.52% |
| 2012-12-31 | $27.88K | -46.21% |
| 2011-12-31 | $51.83K | +226.42% |
| 2010-12-31 | $15.88K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Proto Script Pharmaceutical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 760669300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2016)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $344.14K | % |
| Other Components | $6.95 Million | % |
| Total Equity | $-319.74K | 100.00% |
Proto Script Pharmaceutical Corp Competitors by Market Cap
The table below lists competitors of Proto Script Pharmaceutical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Republic Digital Acquisition Company Warrants
NASDAQ:RDAGW
|
$4.92K |
|
SHANGHAI ELECT -H-
MU:USR
|
$4.92K |
|
GIGLIO.COM S.P.A. O.N.
F:5JR0
|
$4.92K |
|
Arkanova Energy Corporation
PINK:AKVA
|
$4.92K |
|
Fairview International PLC
LSE:FIL
|
$4.90K |
|
Santana Equestrian Private Financial LLC
PINK:SEQP
|
$4.90K |
|
Rooshine Inc
PINK:RSAU
|
$4.89K |
|
BigRep SE
F:B1GR
|
$4.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Proto Script Pharmaceutical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2016 to 2016, total equity changed from -77,062 to -319,736, a change of -242,674.
- Net loss of 7,182,722 reduced equity.
- Dividend payments of 59,593 reduced retained earnings.
- Other factors increased equity by 6,999,641.
Equity Change Factors (2016 to 2016)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.18 Million | -2246.45% |
| Dividends Paid | $59.59K | -18.64% |
| Other Changes | $7.00 Million | +2189.19% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Proto Script Pharmaceutical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | $0.00 | $0.00 | x |
| 2012-12-31 | $0.00 | $0.00 | x |
| 2013-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Proto Script Pharmaceutical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -910.40%
- • Asset Turnover: 4.64x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-60.87%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -63.38% | 0.00% | 0.00x | 1.17x | $-38.03K |
| 2012 | -116.29% | 0.00% | 0.00x | 1.29x | $-35.21K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-35.46K |
| 2014 | -73.94% | -25.23% | 2.09x | 1.40x | $-271.57K |
| 2015 | -233.36% | -16.48% | 4.43x | 3.20x | $-151.47K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.44K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.44K |
| 2016 | 0.00% | -910.40% | 4.64x | 0.00x | $-7.15 Million |
Industry Comparison
This section compares Proto Script Pharmaceutical Corp's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $772,489,888
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Proto Script Pharmaceutical Corp (PSCR) | $-1.44 Million | -63.38% | N/A | $4.91K |
| All American Pet Co (AAPT) | $-1.12 Million | 0.00% | 0.00x | $0.97 |
| ABM Industries Incorporated (ABM) | $61.90 Million | 11.47% | 1.78x | $2.27 Billion |
| ADM Endeavors Inc (ADMQ) | $284.02K | -124.30% | 3.55x | $3.87 Million |
| Amentum Holdings Inc. (AMTM) | $4.55 Billion | -1.80% | 1.63x | $4.20 Billion |
| Anacomp Inc (ANMP) | $101.14 Million | -0.68% | 0.63x | $976.94K |
| Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | $5.65 Million | 2.35% | 0.50x | $30.94 Million |
| Applus Services S.A (APLUF) | $642.95 Million | 7.56% | 2.78x | $16.82 Million |
| ARC Document Solutions Inc (ARC) | $-35.01 Million | 0.00% | 0.00x | $110.98 Million |
| Aramark Holdings (ARMK) | $2.75 Billion | -16.80% | 4.72x | $10.51 Billion |
| Atento S.A. (ATTOF) | $-348.87 Million | 0.00% | 0.00x | $945.48 |